retatrutide weight loss phase 2 trial results VisualAbstract: reduces body by 17.5% in patients with obesity Mazdutide vs retatrutide: dual agonist

Healthcare providers should educate patients about these storage requirements during initial prescribing and reinforce them at follow-up visits

This is not normal, healthy weight loss

CrossRef Integrated lifestyle management to mitigate MASLD risk in patients with chronic kidney disease: a prospective cohort study Chao Yan, Xinxin Shen, Shaojie Han, Jinzheng He, Tongxu Wang, Xiaobing Gong, Jindong Ding Petersen Journal of Translational Medicine .2026;[Epub] CrossRef Retatrutide in type 2 diabetes mellitus and obesity: an overview Theodoros Panou, Evanthia Gouveri, Djordje S

Key Takeaways It's common to regain some weight after stopping a GLP-1 medication

Can I continue taking it during pregnancy

Powered by data from Ro's nationwide platform, the research will evaluate the real-world challenges that patients and providers must navigate in order to access and deliver evidence-based obesity care